Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants

Author:

Tang Bo-Hao1,Wu Yue-E1,Kou Chen2,Qi Yu-Jie3,Qi Hui4,Xu Hai-Yan5,Leroux Stephanie6,Huang Xin7,Zhou Yue1,Zheng Yi1,Jacqz-Aigrain Evelyne8,Shen A-Dong4,Zhao Wei1ORCID

Affiliation:

1. Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan, China

2. Department of Neonatology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China

3. Neonatal Intensive Care Unit, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China

4. Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics (Capital Medical University), Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China

5. Department of Neonatology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China

6. Neonatal Intensive Care Unit, CHU de Rennes, Rennes, France

7. Department of Pharmacy, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China

8. Department of Pediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, APHP, Paris, France

Abstract

Amoxicillin is widely used to treat bacterial infections in neonates. However, considerable intercenter variability in dosage regimens of antibiotics exists in clinical practice.

Funder

National Science and Technology Major Projects for Major New Drugs Innovation and Development

Young Taishan Scholars Program of Shandong Province and Qilu Outstanding Program of Shandong University

Capital Funds for Health Improvement and Research

China Postdoctoral Science Foundation

Capital Health Research and Development of Special

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3